Oncobeta logo

Vumedi Educational Webinar with Dr Sid Baxi

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Non-Melanoma Skin Cancer: Interim Results From the EPIC-Skin Study.

Subscribe to Our Newsletter


Privacy Collection Notice:
OncoBeta Therapeutics Pty Ltd collects the personal information you provide in this form to respond to your enquiry, provide the services or information you have requested, and for our general business operations.

We will also use your contact details to send you news, updates, and marketing communications. You can unsubscribe from these communications at any time.

Providing the mandatory fields (typically marked with an asterisk *) is required for us to process your request. If you do not provide this information, we may not be able to assist you.

We handle your information securely and in accordance with our Privacy Policy, which explains how we collect, use, store, and disclose your personal information.

Phone : +61 (0)7 3012 6343

Email : admin-au@oncobeta.com

Patients

Healthcare Professionals

Rhenium-SCT®

Company

Acknowledgement
We acknowledge the cultures of our First Nations Peoples and are thankful for the community that we share together now. We pay our respects to our First Nations Peoples and their elders, both past,  present, and those who are rising up to become leaders.

Consent Preferences

© 2026 Oncobeta Therapeutics Pty Ltd. All Rights Reserved.